SPECTRUM PHARMACEUTICALS INC Restricted Stock or Unit Expense
SPECTRUM PHARMACEUTICALS INC reported Restricted Stock or Unit Expense of $6.82 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-07.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestrictedStockExpense · last filed 2018-03-07
- SPECTRUM PHARMACEUTICALS INC restricted stock or unit expense for fiscal 2017 was $6.82M, a 4.65% increase from fiscal 2016.
- SPECTRUM PHARMACEUTICALS INC restricted stock or unit expense for fiscal 2016 was $6.52M, a 49.53% increase from fiscal 2015.
- SPECTRUM PHARMACEUTICALS INC restricted stock or unit expense for fiscal 2015 was $4.36M, a 13.81% increase from fiscal 2014.
- SPECTRUM PHARMACEUTICALS INC restricted stock or unit expense for fiscal 2014 was $3.83M, a 8.85% decline from fiscal 2013.
| Period end | Restricted Stock or Unit Expense 12 month | Restricted Stock or Unit Expense 12 month as first filed |
|---|---|---|
| 2017-12-31 | $6.82M 10-K · filed 2018-03-07 | |
| 2016-12-31 | $6.52M 10-K · filed 2018-03-07 | $6.00M 10-K · filed 2017-03-14 |
| 2015-12-31 | $4.36M 10-K · filed 2018-03-07 | $4.01M 10-K · filed 2016-03-14 |
| 2014-12-31 | $3.83M 10-K · filed 2017-03-14 | |
| 2013-12-31 | $4.20M 10-K · filed 2016-03-14 | |
| 2012-12-31 | $6.50M 10-K · filed 2015-03-13 | |
| 2011-12-31 | $4.10M 10-K · filed 2014-03-12 | |
| 2010-12-31 | $974.00K 10-K/A · filed 2013-12-06 |